Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

TriSalus Life Sciences, Inc. (TLSI)

NASDAQ

$4.72

$-0.27

(-5.40%)

Pre-Market

TriSalus Life Sciences, Inc. (TLSI) Live Price Chart

Last updated: ⁦2026-09-09 10:37:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

TriSalus Life Sciences, Inc. (TLSI) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $4.72, with a market capitalization of $307.87M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.20 to $7.95. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$307.87M
Open	$4.94
Day's High	$16.24
Day's Low	$2.20
Previous Close	$5.00
Volume	105.37K
Average Volume	291.11K
P/E Ratio	--
52-Week High	$7.95
52-Week Low	$2.20
Dividend Yield	--
Earnings Date	--

TriSalus Life Sciences, Inc. (TLSI) Pre-Market Stock Price

TriSalus Life Sciences, Inc. (TLSI) is trading at $4.98 in pre-market trading as of 2026-09-08 23:31:00, down 0.40% ($0.02) from the previous close of $5.00

Pre-market trading shows how investors are pricing TLSI before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

TriSalus Life Sciences, Inc. (TLSI) 7-Day Stock Price Change

Over the past seven days, TriSalus Life Sciences, Inc. (TLSI) moved from $4.83 to $4.72, representing a decline of 2.19% ($0.11).

The stock traded between $4.48 and $5.37 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 110.33 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

TLSI 52-Week Price Position

Position in Range: 43.9%

52W Low$2.20

52W High$7.95

TLSI is currently trading at $4.72, placing it 43.9% of the way from its 52-week low of $2.20 to its 52-week high of $7.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is TriSalus Life Sciences, Inc. (TLSI)?

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

TriSalus Life Sciences, Inc. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	102
Exchange	NASDAQ
Company Website	https://www.trisaluslifesci.com

How to Buy TriSalus Life Sciences, Inc. (TLSI) Stock on MEXC

Eligible investors can buy real shares of TriSalus Life Sciences, Inc. (TLSI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TLSI and Place Your Order

Open the RealStocks trading page and search for TLSI. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is TriSalus Life Sciences, Inc. (TLSI) stock price today?

TriSalus Life Sciences, Inc. (TLSI) is currently trading at $ 4.72, down 5.52% ($0.28) from the previous close of $ 5.00. Intraday prices update in real time during regular trading hours.

2.Is TLSI stock going up or down today?

As of 2026-09-08 23:31:00, TLSI is trading at $ 4.72, down 5.52% ($0.28) from its previous close of $ 5.00. The stock has traded between $ 2.20 and $ 16.24 during today’s regular session. Past price movements do not guarantee future results.

3.What is TLSI pre-market price?

As of 2026-09-08 23:31:00, TLSI is trading at $ 4.98 in pre-market trading, down 0.40% ($0.02) from the previous close of $ 5.00. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TLSI after-hours price?

As of 2026-09-08 23:31:00, TLSI is trading at $ 4.74 in after-hours trading, down 5.30% ($0.26) from the regular-session close of $ 5.00. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TLSI stock trading now?

TLSI trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TLSI sit relative to its 52-week high and low?

Over the past 52 weeks, TLSI has traded between a low of $ 2.20 and a high of $ 7.95. At $ 4.72, the stock is positioned 43.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is TriSalus Life Sciences, Inc. in?

TriSalus Life Sciences, Inc. (TLSI) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is TriSalus Life Sciences, Inc.'s market capitalization and where is it listed?

TriSalus Life Sciences, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 307.87M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TLSI valued in terms of P/E ratio and EPS?

TLSI trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.95. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does TriSalus Life Sciences, Inc. pay a dividend?

TriSalus Life Sciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.